Threshold Pharmaceuticals, Inc. Share Price Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Sales 2024 * | 12.7M 1.01B | Sales 2025 * | 1.37M 109M | Capitalization | 9.81M 779M |
---|---|---|---|---|---|
Net income 2024 * | -22M -1.75B | Net income 2025 * | -34M -2.7B | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 7.18 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 31/12/99 |
Jason Kim
PSD | President | 49 | 31/12/09 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 31/12/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 31/12/99 |
Harold Selick
CHM | Chairman | 69 | 31/07/17 |
David Hoffmann
BRD | Director/Board Member | 79 | 31/07/17 |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.70% | 21.25B | |
-6.03% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+5.10% | 13.94B | |
+37.57% | 12.54B |